TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics, Inc.
Curated by ChEMBL
Fimbrion Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 30nMAssay Description:Inhibition of Escherichia coli UTI89 FimH-mediated biofilm formation after 48 hrs by crystal violet staining-based assayMore data for this Ligand-Target Pair
TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics, Inc.
Curated by ChEMBL
Fimbrion Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 40nMAssay Description:Inhibition of Escherichia coli UTI89 FimH-mediated biofilm formation after 48 hrs by crystal violet staining-based assayMore data for this Ligand-Target Pair
TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics, Inc.
Curated by ChEMBL
Fimbrion Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 40nMAssay Description:Inhibition of Escherichia coli UTI89 FimH-mediated biofilm formation after 48 hrs by crystal violet staining-based assayMore data for this Ligand-Target Pair
TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics, Inc.
Curated by ChEMBL
Fimbrion Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 80nMAssay Description:Inhibition of Escherichia coli UTI89 FimH-mediated biofilm formation after 48 hrs by crystal violet staining-based assayMore data for this Ligand-Target Pair
TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics, Inc.
Curated by ChEMBL
Fimbrion Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 130nMAssay Description:Inhibition of Escherichia coli UTI89 FimH-mediated biofilm formation after 48 hrs by crystal violet staining-based assayMore data for this Ligand-Target Pair
TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics, Inc.
Curated by ChEMBL
Fimbrion Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 140nMAssay Description:Inhibition of Escherichia coli UTI89 FimH-mediated biofilm formation after 48 hrs by crystal violet staining-based assayMore data for this Ligand-Target Pair
TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics, Inc.
Curated by ChEMBL
Fimbrion Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 150nMAssay Description:Inhibition of Escherichia coli UTI89 FimH-mediated biofilm formation after 48 hrs by crystal violet staining-based assayMore data for this Ligand-Target Pair
TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics, Inc.
Curated by ChEMBL
Fimbrion Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 250nMAssay Description:Inhibition of Escherichia coli UTI89 FimH-mediated biofilm formation after 48 hrs by crystal violet staining-based assayMore data for this Ligand-Target Pair
TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics, Inc.
Curated by ChEMBL
Fimbrion Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 340nMAssay Description:Inhibition of Escherichia coli UTI89 FimH-mediated biofilm formation after 48 hrs by crystal violet staining-based assayMore data for this Ligand-Target Pair
TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics, Inc.
Curated by ChEMBL
Fimbrion Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 600nMAssay Description:Inhibition of Escherichia coli UTI89 FimH-mediated biofilm formation after 48 hrs by crystal violet staining-based assayMore data for this Ligand-Target Pair
TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics, Inc.
Curated by ChEMBL
Fimbrion Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 900nMAssay Description:Inhibition of Escherichia coli UTI89 FimH-mediated biofilm formation after 48 hrs by crystal violet staining-based assayMore data for this Ligand-Target Pair
TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics, Inc.
Curated by ChEMBL
Fimbrion Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 1.35E+3nMAssay Description:Inhibition of Escherichia coli UTI89 FimH-mediated biofilm formation after 48 hrs by crystal violet staining-based assayMore data for this Ligand-Target Pair
TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics, Inc.
Curated by ChEMBL
Fimbrion Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 1.10E+4nMAssay Description:Inhibition of Escherichia coli UTI89 FimH-mediated biofilm formation after 48 hrs by crystal violet staining-based assayMore data for this Ligand-Target Pair
TargetType 1 fimbiral adhesin FimH(Escherichia coli (strain UTI89 / UPEC))
Fimbrion Therapeutics, Inc.
Curated by ChEMBL
Fimbrion Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 3.80E+4nMAssay Description:Inhibition of Escherichia coli UTI89 FimH-mediated biofilm formation after 48 hrs by crystal violet staining-based assayMore data for this Ligand-Target Pair